NL-OMON30579
Not yet recruiting
Not Applicable
Sodium Oxybate for the Treatment of Vigilance Impairment in Narcolepsy - Sodium Oxybate and Vigilance in Narcolepsy
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Narcolepsy
- Sponsor
- Academisch Medisch Centrum
- Enrollment
- 40
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Definite narcolepsy\-cataplexy, according to international criteria \[AASM 2005],
- •\- Patients have to be treatment\-naive and planning to start sodium oxybate or already using sodium oxybate and prepared to stop medication at least 14 days prior to study start
Exclusion Criteria
- •\- Younger than 18 or older than 70 years
- •\- Cognitive impairment due to neurological disorders other than sleep\-wake disorders
- •\- Use of other hypnotics or other sleep\-wake active drugs
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
Sodium-oxybate as a potential new treatment for catatonia in patients with depression, bipolar disorder or a psychotic disorder, a randomized controlled trial. The Laborit study.KatatonieCatatoniasyndrome associated with psychomotor disturbanceswith either a retarded or excited nature10037176NL-OMON56950Amsterdam UMC42
Not yet recruiting
Phase 3
Sodium-oxybate as a potential new treatment for catatonia in patients with depression, bipolar disorder or a psychotic disorder, a randomized controlled trial. The Laborit study.KatatonieCatatoniasyndrome associated with psychomotor disturbanceswith either a retarded or excited nature10037176NL-OMON54182Amsterdam UMC42
Active, not recruiting
Phase 3
Sodium oxybate as a potential new treatment for catatonia in patients with depression, bipolar disorder or a psychotic disorderTreatment of catatonia in adult patients with unipolar depression, bipolar disorder or psychotic disorders, that do not sufficiently benefit from treatment with lorazepam.Mental and Behavioural DisordersISRCTN11236443Amsterdam UMC Location VUmc42
Active, not recruiting
Phase 1
Efficacy and safety of Sodium Oxybate in reducing alcohol consumption and maintaining abstinence in alcohol-dependent subjects with high and very high drinking risk levelAlcohol addictionTherapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]CTIS2023-506990-37-00aboratorio Farmaceutico C.T. S.r.l.51
Active, not recruiting
Phase 1
OXYTAHANE - Oxygen therapy: Acute Treatment for paroxysmal dystonic or plegic attacks in alternating hemiplegia of childhoodAlternating Hemiplegia of ChildhoodTherapeutic area: Diseases [C] - Nervous System Diseases [C10]CTIS2023-508413-16-00Assistance Publique Hopitaux De Paris24